Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

85 trials

NCT06458010
Recruiting
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
Early phase 1 · China · 1 site
Registry update: 30 Apr 2025
NCT06164730
Recruiting
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Phase 1 · Australia, Canada, United Kingdom, Israel, New Zealand, United States · 27 sites
Registry update: 2 Sept 2026
NCT06374277
Recruiting
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Not applicable · United States · 2 sites
Registry update: 29 Jan 2026
NCT06314919
Recruiting
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Not applicable · South Korea · 1 site
Registry update: 12 Sept 2025
NCT04941599
Recruiting
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Phase 2 · United States · 1 site
Registry update: 7 Aug 2026
NCT05614219
Recruiting
Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
Not applicable · Denmark · 2 sites
Registry update: 20 Feb 2026
NCT06192251
Recruiting
Complete Lifestyle Medicine Intervention Program
Not applicable · Canada · 1 site
Registry update: 8 Jan 2024
NCT06125847
Recruiting
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
Early phase 1 · China · 1 site
Registry update: 3 Sept 2026
NCT05348564
Recruiting
Comparing Direct vs Indirect Methods for Cascade Screening
Not applicable · United States · 1 site
Registry update: 14 Apr 2026
NCT05693701
Recruiting
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Not applicable · United States · 1 site
Registry update: 17 Mar 2026
NCT05682378
Recruiting
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
Phase 3 · Argentina, Brazil, Canada, Switzerland, Czechia, Germany, Spain, France, United Kingdom, Greece, Hungary, Israel, Italy, Jordan, Lebanon, Malaysia, Netherlands, Norway, Poland, Russia, Slovenia, Slovakia, Taiwan, United States, South Africa · 47 sites
Registry update: 18 Sept 2026
NCT06287177
Recruiting
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
Not applicable · Italy · 1 site
Registry update: 22 Jan 2026
NCT05325034
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Not applicable · Australia, China, India, Japan, South Korea, Malaysia, Singapore, Thailand, Taiwan · 22 sites
Registry update: 8 Oct 2026
NCT05430828
Recruiting
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
Not applicable · Italy · 27 sites
Registry update: 22 Jan 2026
NCT04485871
Recruiting
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
Not applicable · Canada · 1 site
Registry update: 12 Mar 2026
NCT03480568
Recruiting
Alirocumab in Patients on a Stable Dialysis Regimen
Phase 3 · United States · 1 site
Registry update: 12 Feb 2020
NCT04815005
Recruiting
HoFH, the International Clinical Collaborators Registry
Not applicable · Netherlands, United States, South Africa · 4 sites
Registry update: 18 Dec 2025
NCT06362473
Recruiting
Lipid Transport Disorder Italian Genetic Record (LIPIGEN)
Not applicable · Italy · 1 site
Registry update: 10 Nov 2026
NCT04272697
Recruiting
EAS Familial Hypercholesterolaemia Studies Collaboration
Not applicable · United Kingdom · 1 site
Registry update: 4 Mar 2026
NCT02208869
Recruiting
Russian Familial Hypercholesterolemia Registry
Not applicable · Russia · 5 sites
Registry update: 2 Nov 2022

Ordered by registry start date. Freshness and sponsorship never change the order.